S-1 EX-FILING FEES 0002022416 N/A N/A 0002022416 1 2025-08-26 2025-08-26 0002022416 2025-08-26 2025-08-26 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Silexion Therapeutics Corp

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary shares, par value $0.0135 per share   (1)   Other   314,859   $ 6.9425   $ 2,185,908.61   0.0001531   $ 334.67
                                           
Total Offering Amounts:   $ 2,185,908.61         334.67
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 334.67

__________________________________________
Offering Note(s)

(1) (1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional ordinary shares, par value $0.0135 per share ("ordinary shares"), of Silexion Therapeutics Corp that may be offered or become issuable by reason of any share dividend, share split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of outstanding ordinary shares.
(2) Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act and based upon the average of the high and low sales prices of the ordinary shares as reported on the Nasdaq Capital Market on August 22, 2025.
(3) Consists of (i) 304,212 ordinary shares issuable upon the exercise of new warrants issued to certain holders in connection with the warrant exercise inducement transaction, and (ii) 10,647 ordinary shares issuable upon the exercise of new warrants issued to the placement agent in connection with the warrant exercise inducement transaction.